Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
5 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
6 days ago
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Positive maternal, foetal outcomes possible following antenatal chemotherapy in women with cancer

Elaine Soliven
30 Nov 2017

Antenatal chemotherapy may not necessarily result in poor neonatal outcomes in women diagnosed with cancer during pregnancy, according to a study presented at ESMO Asia 2017.

“Results are mainly reassuring, the effect of pregnancy on the maternal outcome does not seem to be negative and [antenatal chemotherapy] is not an independent risk factor for a worse maternal outcome. We also found reassuring results on the effects of antenatal therapy on foetal safety,” said lead author Dr Jorine de Haan from the Department of Obstetrics & Gynaecology at KU Leuven, Leuven, Belgium.

Using data from the INCIP* database, researchers conducted an international cohort study involving 1,170 patients diagnosed with a primary cancer during pregnancy between 1996 and 2016. Primary outcome measures included small-for-gestational-age (SGA) and neonatal intensive care unit (NICU) admission.

Breast cancer was the most common cancer diagnosed during pregnancy (39 percent, n=462), followed by cervical cancer (13 percent, n=147), lymphoma (10 percent, n=113), ovarian cancer (7 percent, n=88), and leukaemia (6 percent, n=68).

Researchers evaluated the participants every 5 years for over 20 years. Over time, changes in oncological management and obstetrical outcome were observed, where more pregnant women with cancer were treated with chemotherapy (risk ratio [RR], 1.31) and there were more live births (RR, 1.04).

Eighty-three percent of patients underwent antenatal chemotherapy only with ≥1 chemotherapeutic agents.

There was a lower incidence of preterm births (RR, 0.93), iatrogenic preterm births (RR, 0.91), and NICU admission (RR, 0.91) among infants of patients treated with antenatal chemotherapy.

However, there was a higher likelihood of infants being small-for-gestational-age (SGA; RR, 1.16), though SGA was also associated with higher maternal age (odds ratio [OR], 1.36), systemic disease in patients diagnosed with cancer during pregnancy (OR, 1.86), and the use of platinum-based chemotherapy (OR, 3.12).

Although antenatal chemotherapy was the most common treatment given in this study, de Haan suggested that a management plan should be considered, which involves a multidisciplinary team approach in treating pregnant women diagnosed with cancer.

Further studies are warranted to elucidate the association between SGA and chemotherapy, said the researchers, who called for a long-term follow-up of children exposed to chemotherapy.

 

*INCIP: International Network on Cancer Infertility and Pregnancy

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
5 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
6 days ago
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.